Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

It Takes a Team: Treating Adverse Events

Sunday, March 31, 2019

When treating patients with chemotherapy plus an immunotherapy agent, a multidisciplinary team should be on call to manage adverse events (AEs), explained Matthew A. Gubens, MD, MS, associate professor of thoracic medical oncology at the UCSF Helen Diller Family Comprehensive Cancer Center. 

The combination is usually well-tolerated, with typical chemotherapy AEs occurring, such as nausea and vomiting. When it comes to immunotherapy, the same AEs that would be expected if the drug was given as a single agent could be expected, Gubens said. 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Related Videos
By: Raymond Chan, PhD, RN, BN, MAppSc
By: Grace Campbell, PhD, MSW, RN, CNL, CRRN
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.